Covid-19 Updates | Cell and Advanced Therapies Supply Chain Management Market, 2021-2030
Advanced therapy medicinal products, such as cell and gene therapies, have revolutionized healthcare practices. The introduction of such treatment options has led to a paradigm shift in drug development, production and consumption.

Presently,over 160 innovative, software enabled systems are being used to efficientlymanage and streamline various aspects of the complex supply chain of cell andadvanced therapies

TheUSD 1.5 billion (by 2030) financial opportunity within the cell and advanced therapy supply chainmanagement software solutions markethas been analysed across the following segments:

KeyMarket Insights

·       Presently, over 160 innovative,software-enabled systems are being used to efficiently manage and streamlinevarious aspects of the complex supply chain of cell and advanced therapies

·       Company involved in this domain are puttingin significant efforts to develop advanced software solutions and alsodifferentiate their offerings, from those of other industry players, in orderto maintain a competitive edge

·       North America is the major hub of innovationin this field, serving as the base for companies of all sizes, which are primarilyengaged in developing cloud-based solutions for diverse applications

·       The cell and advanced therapies market ischaracterized by an elaborate value chain, involving a multitude of processesand several stakeholders, each having a discrete set of priorities andrequirements

·       Increase in partnership activity reflects thegrowing interest of stakeholders in this industry; over 50% of reported dealswere established to deploy software solutions for enhancing visibility andsupply chain performance

·       An analysis of recent activity on Twitterreveals the increasing interest and ongoing efforts of industry stakeholders inproviding needle-to-needle traceability and supply chain orchestrationsolutions

·       Given their cost saving potential acrossdifferent processes and operations, we expect the cell and advanced therapysupply chain solutions market to grow at an annualized rate of around 25% overthe next decade

·       In the mid-long term, the projectedopportunity is anticipated to be well distributed across various globalregions, different end uses / applications and mode of deployment of variousproprietary software solutions

Kwonmore @ Celland Advanced Therapies Supply Chain Management Market Size

Applicationarea

·       Sample collection and processing

·       Manufacturing

·       Logistics

·       Patient identification and treatmentfollow-up

Typeof software solution

·       Cell orchestration platform

·       Enterprise manufacturing system

·       Inventory management system

·       Laboratory information management system

·       Logistics management system

·       Patient management system

·       Quality management system

Modeof Deployment

·       Cloud-based solution

·       On-premises solution

Scaleof Operation

·       Clinical

·       Commercial

Enduser

·       Biobank

·       Cell therapy lab / commercial organization

·       Hospital / medical center

·       Research institute

Keygeographical regions

·       North America

·       Europe

·       Asia Pacific

·       Rest of the world

GetCustomized Report @ Celland Advanced Therapies Supply Chain Management

keyplayers

·       Be The Match BioTherapies®

·       Brooks Life Sciences

·       Clarkston Consulting

·       Cryoport

·       Haemonetics

·       Hypertrust Patient Data Care

·       Lykan Bioscience

·       MAK-SYSTEM

·       MasterControl

·       SAP

·       SAVSU Technologies

·       sedApta Group

·       Stafa Cellular Therapy

·       Title21 Health Solutions

·       TraceLink

·       TrakCel

·       Vineti

Tableof Contents

1.    Preface

2.    ExecutiveSummary

3.    Introduction

4.    CurrentMarket Landscape

5.    CompanyCompetitiveness Analysis

6.    Celland Advanced Therapies Supply Chain Management: Company Profiles

7.    SupplyChain Orchestration Platform: Emerging Trends and Key Players

8.    Fundingand Investment Analysis

9.    Partnershipsand Collaborations

10. SupplyChain Utilization Use Cases

11. StakeholderNeeds Analysis

12. CostSavings Analysis

13. MarketForecast

14. ExecutiveInsights

15. ConcludingRemarks

16. Appendix1: List of Additional Supply Chain Management Software Solutions

17. Appendix2: Tabulated Data

18. Appendix3: List of Companies and Organizations

Topurchase a copy, please visit https://www.rootsanalysis.com/reports/260/request-sample.html

AlsoVisit Our Latest Publication:

1.      Organ–based / Targeted Drug DeliveryDevices Market for Biologics (Intra-organ / Intra-tumoral), 2020 - 2030

2.      Global Handheld Ultrasound ImagingDevices Market, 2020-2030

3.      Large Volume Wearable InjectorsMarket (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous DeliveryDevices

4.      Medical DeviceCROs Market (2nd Edition), 2020 – 2030

 

AboutRoots Analysis

RootsAnalysis isone of the fastest growing market research companies, sharing fresh andindependent perspectives in the bio-pharmaceutical industry. The in-depthresearch, analysis and insights are driven by an experienced leadership teamwhich has gained many years of significant experience in this sector.

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415

[email protected]

YOUR REACTION?


You may also like

Facebook Conversations



Disqus Conversations